October 24, 2026
Celebrating Caregivers – "The People Who Keep Showing Up for You"
Read Ester's story and insights on caregiving while living with hereditary ATTR amyloidosis, including lessons on resilience, support, and self-care.
Read More ›
October 15, 2026
The Signs Were There: How Pete Shaw and His Team Faced an Unexpected Opponent
For former professional football player Pete Shaw, recognizing the signs of hATTR-CM meant looking beyond the expected. Read his story and path to answers.
Read More ›
August 26, 2026
Advancing Earlier Diagnosis and Coordinated Care in ATTR-CM
For patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), the path to effective care often begins with a challenge: receiving the right diagnosis before the disease irreversibly advances.
Read More ›
March 27, 2026
Five Things to Know about TRITON-CM & How Community Insight is Shaping the Future of ATTR- ...
TRITON-CM, Alnylam's Phase 3 clinical trial evaluating nucresiran, a third-generation investigational RNAi therapeutic for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), represents one of the largest global studies ever conducted in this disease.
Read More ›
October 24, 2025
Looking Beyond the Clinic: Putting Patients at the Center of Holistic Care in Transthyreti ...
Enhancing understanding of this life-threatening disease and ensuring that care reflects the realities of those living with it are vital goals shared across the
Read More ›
October 20, 2025
Alnylam’s Commitment to Health Literacy for All
As a patient-centric organization, Alnylam is fully committed to promoting the principles of health literacy as an integral part of our innovation and culture.
Read More ›
September 6, 2023
First Consensus Recommendations for Holistic Care of People Living With Hereditary ATTR Am ...
The Amyloidosis Alliance has published the first-ever consensus recommendations for patient- and family-centred holistic care in ATTRv.
Read More ›
February 28, 2023
The Importance of Self-Advocacy: Supporting Patients and Caregivers in Their Rare Disease ...
Rare Disease Day unites the community to spread awareness and support the millions of people worldwide living with with a rare disease.
Read More ›
May 9, 2022
Building a Collaborative Framework for Facilitating Patient Access to Innovative Therapies
Alnylam worked with leading European economists and other healthcare experts to develop what we call the Value-Based Negotiation Framework (VBNF) to help...
Read More ›
April 2, 2022
The Making of Two of Me: Living with Porphyria
Cynthia Lowen, Emmy-nominated filmmaker, talks about the making of Two of Me: Living with Porphyria.
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site